BEAM Feb 2023 50.000 call
OPR - OPR Delayed price. Currency in USD
Add to watchlist
As of 10:14AM EDT. Market open.
| Previous close | 23.28 |
| Open | N/A |
| Bid | 24.30 |
| Ask | 27.00 |
| Strike | 50.00 |
| Expiry date | 2023-02-17 |
| Day's range | 23.28 - 25.80 |
| Contract range | N/A |
| Volume | |
| Open interest | 16 |
- Motley Fool
Why Beam Therapeutics Stock Rocketed Higher This Week
Shares of the clinical-stage base-editing company Beam Therapeutics (NASDAQ: BEAM) stormed higher through the first four days of trading this week. Beam's sizable uptick seems to simply be a rebound following last week's 23% drop in its share price. Clinical-stage biotech stocks have been extremely volatile this year, thanks to rising interest rates, geopolitical turmoil, and investors' general aversion to risk right now.
- Zacks
Beam Therapeutics Inc. (BEAM) Reports Q2 Loss, Tops Revenue Estimates
Beam Therapeutics Inc. (BEAM) delivered earnings and revenue surprises of 5.56% and 26.87%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
- Simply Wall St.
Even after rising 8.2% this past week, Beam Therapeutics (NASDAQ:BEAM) shareholders are still down 40% over the past year
Beam Therapeutics Inc. ( NASDAQ:BEAM ) shareholders will doubtless be very grateful to see the share price up 78% in...
© 2022 Yahoo. All rights reserved.
